Physician profile
Ido Friedman
NPI 1417953886
$2,432.45
in general payments reported to CMS, 2019-2025
23 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $51.04 · 2021: $13.04 · 2022: $55.95 · 2023: $144 · 2024: $1,580 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461 · Travel and Lodging: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.16 |
| Travel and Lodging | $579.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,260.26 | 2023-2024 | |
| Bone Support INC. | $154.86 | 2024 | Ceramentbone Void Filler, Cerament G |
| Pacira Pharmaceuticals Incorporated | $118.25 | 2019 | |
| Melinta Therapeutics, LLC | $116.11 | 2019 | |
| Globus Medical, INC. | $87.11 | 2025 | Senza |
| Organogenesis INC. | $80.24 | 2022-2025 | Affinity |
| Averitas Pharma INC. | $76.54 | 2023-2024 | Qutenza |
| Smith+Nephew, INC. | $72.45 | 2020-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Amgen INC. | $68.77 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $68.22 | 2019-2023 | Krystexxa |
| Ani Pharmaceuticals, INC. | $63.81 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $53.03 | 2023-2025 | |
| Aroa Biosurgery Incorporated | $34.08 | 2020 | |
| Kerecis Limited | $27.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Wright Medical Technology, INC. | $26.58 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $20.28 | 2025 | Nuzyra |
| Nevro Corp. | $18.12 | 2024 | Senza |
| Triad Life Sciences INC. | $16.40 | 2022 | |
| Bioventus LLC | $15.94 | 2025 | Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $14.92 | 2025 | Irrisept |
| Medtronic, INC. | $14.25 | 2024 | Intellis Adaptivestim |
| Cashflow Solutions, LLC | $13.19 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kowa Pharmaceuticals America, INC. | $11.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ido Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.